1-5 of 5
Victoria Sukholutsky
Close
Sort by
Journal Articles

Discontinuation of HMA Therapy after Achieving Complete or Partial Response: Retrospective Analysis of Survival after Long-Term Follow up

Monica Cabrero, MD, Elias Jabbour, MD, Naval Daver, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MD, Jorge E. Cortes, MD, Zach Bohannan, Victoria Sukholutsky, Farhad Ravandi, MD, Sherry Pierce, BSN, BA, Tapan Kadia, MD, Naveen Pemmaraju, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2014) 124 (21): 4664.
https://doi.org/10.1182/blood.V124.21.4664.4664
Published: 2014
Journal Articles

Comparison of Continuation of HMA Vs Allogeneic Stem Cell Transplant and Its Timing in Myelodysplastic Syndromes: Can It Wait? Results of a Retrospective Study

Monica Cabrero, MD, Guillermo Garcia-Manero, MD, Koji Sasaki, Naval Daver, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MD, Jorge E. Cortes, MD, Zach Bohannan, Victoria Sukholutsky, Farhad Ravandi, MD, Sherry Pierce, BSN, BA, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Betul Oran, MD, Richard E. Champlin, Hagop Kantarjian, MD, Elias Jabbour, MD
Journal: Blood
Blood (2014) 124 (21): 4666.
https://doi.org/10.1182/blood.V124.21.4666.4666
Published: 2014
Journal Articles

Temporal Acquisition of FLT3-ITD or RAS Mutation at Transformation to AML from MDS: Clinical Implications

Talha Badar, MBBS,FCPS, Philip A Thompson, MBBS, Binsah George, MD, Naval Daver, MD, Gautam Borthakur, MD, Jorge E. Cortes, MD, Marina Konopleva, MD PhD, Tapan M. Kadia, MD, Zach Bohannan, Sherry Pierce, BSN, BA, Elias Jabbour, MD, Farhad Ravandi, MD, Hagop M. Kantarjian, MD, Keyur P. Patel, MD PhD, Raja Luthra, Victoria Sukholutsky, Guillermo Garcia Manero, MD
Journal: Blood
Blood (2014) 124 (21): 4631.
https://doi.org/10.1182/blood.V124.21.4631.4631
Published: 2014
Journal Articles

Initial Results of a Randomized Phase II Study of Low Dose Decitabine (DAC) Versus Low Dose Azacitidine (AZA) in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes (MDS)

Elias Jabbour, MD, Koji Sasaki, Naval Daver, MD, Naveen Pemmaraju, MD, Courtney D. DiNardo, MD, Tapan Kadia, MD, Darla Miller, Victoria Sukholutsky, Xuelin Huang, PhD, Gautam Borthakur, MD, Zeev Estrov, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2014) 124 (21): 4640.
https://doi.org/10.1182/blood.V124.21.4640.4640
Published: 2014
Journal Articles

A Bayesian Phase II Randomized Trial of Azacitidine Versus Azacitidine + Vorinostat in Patients with Newly Diagnosed AML or High-Risk MDS with Poor Performance Status, Organ Dysfunction, or Other Comorbidities

Guillermo Garcia-Manero, MD, Xuelin Huang, PhD, Monica Cabrero, MD, Courtney D. DiNardo, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Gautam Borthakur, MD, William G Wierda, MDPhD, Tapan Kadia, MD, Yesid Alvarado, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Farhad Ravandi, MD, Elias Jabbour, MD, Mark Brandt, Troy Sneed, Research Nurse, Victoria Sukholutsky, Sherry Pierce, BSN, BA, Zachary Bohannan, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2014) 124 (21): 3277.
https://doi.org/10.1182/blood.V124.21.3277.3277
Published: 2014